Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
US5864018A · kind A · utility
74Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 1996 |
| Grant date | Jan 26, 1999 |
| Priority date | — |
| Expiry date | Apr 16, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It is a general object of the present invention to provide compositions that specifically interact with advanced glycosylation end products (AGEs) or their receptors. Such compositions may be used in a variety of applications including therapeutic applications, e.g., as blocking agents to inhibit or otherwise reduce the AGE/RAGE interaction, screening applications, e.g., as models of the AGE/RAGE interaction, and diagnostic applications, e.g., to identify abnormal levels of AGE or RAGE in a given system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.